The ADVANCE study: a groundbreaking trial to evaluate a candidate universal antiretroviral regimen

PURPOSE OF REVIEW: Current WHO-recommended first-line therapy in low-income and middle-income countries has been very successful in saving millions of lives but still has toxicity concerns and a low barrier to resistance. RECENT FINDINGS: Two candidate antiretrovirals may substantially transform fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Venter, Willem D.F., Clayden, Polly, Serenata, Celicia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
TOWARDS A UNIVERSAL ANTIRETROVIRAL REGIMEN: Edited by Charles W. Flexner, Willem D.F. Venter, and Polly Clayden
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459583/
https://www.ncbi.nlm.nih.gov/pubmed/28538284
http://dx.doi.org/10.1097/COH.0000000000000389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459583/
https://www.ncbi.nlm.nih.gov/pubmed/28538284
http://dx.doi.org/10.1097/COH.0000000000000389

Ejemplares similares